Evidence map›Paper›PMID 21502325›Full record

ArticleThe Journal of biological chemistry2011

Ferryl derivatives of human indoleamine 2,3-dioxygenase.

Changyuan Lu, Syun-Ru Yeh

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Inhibition Mechanisms of Human Indoleamine 2,3 Dioxygenase 1.Journal of the American Chemical Society · 2018
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Indole peroxygenase activity of indoleamine 2,3-dioxygenase.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  11. NADH oxidase activity of indoleamine 2,3-dioxygenase.The Journal of biological chemistry · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Changyuan LuDepartment of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Syun-Ru Yeh
Albert Einstein College of Medicine · US

Funding

Catalytic and Inhibitory Mechanisms in Indoleamine 2,3-dioxygenaseR01GM086482 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI YEH, SYUN-RU · 2010 to 2013
$1.3M
NIGMS NIH HHS GM086482NIGMS NIH HHS R01 GM086482
6 · The paper itself

Abstract

The critical role of the ferryl intermediate in catalyzing the oxygen chemistry of monooxygenases, oxidases, or peroxidases has been known for decades. In contrast, its involvement in heme-based dioxygenases, such as human indoleamine 2,3-dioxygenase (hIDO), was not recognized until recently. In this study, H(2)O(2) was used as a surrogate to generate the ferryl intermediate of hIDO. Spectroscopic data demonstrate that the ferryl species is capable of oxidizing azinobis(3-ethylbenzothiazoline-6-sulfonic acid) but not L-Trp. Kinetic studies reveal that the conversion of the ferric enzyme to the ferryl intermediate facilitates the L-Trp binding rate by >400-fold; conversely, L-Trp binding to the enzyme retards the peroxide reaction rate by ∼9-fold, because of the significant elevation of the entropic barrier. The unfavorable entropic factor for the peroxide reaction highlights the scenario that the structure of hIDO is not optimized for utilizing H(2)O(2) as a co-substrate for oxidizing L-Trp. Titration studies show that the ferryl intermediate possesses two substrate-binding sites with a K(d) of 0.3 and 440 μM and that the electronic properties of the ferryl moiety are sensitive to the occupancy of the two substrate-binding sites. The implications of the data are discussed in the context of the structural and functional relationships of the enzyme.

Indexed as

Binding SitesBiophysicsCatalysisElectronicsHumansHydrogen PeroxideIndoleamine-Pyrrole 2,3,-DioxygenaseIronKineticsOxygenPeroxidesProtein BindingSpectrophotometrySpectrum Analysis, RamanThermodynamicsHydrogen PeroxideIndoleamine-Pyrrole 2,3,-DioxygenaseIronOxygenPeroxides

Identifiers

PMID21502325
PMCPMC3283129
OpenAlexW2026421056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.